Brief: Lantern Pharma Receives Certificate Of Patent From Japanese Patent Office For Composition Of Matter Covering Drug Candidate LP-284
12/06/2024 13:08
June 12 (Reuters) - Lantern Pharma Inc LTRN.O :
* LANTERN PHARMA RECEIVES CERTIFICATE OF PATENT FROM
JAPANESE
PATENT OFFICE (JPO) FOR COMPOSITION OF MATTER COVERING DRUG
CANDIDATE LP-284
Source text for Eikon: ID:nBw7Y6Yjfa
Further company coverage: LTRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lantern Pharma
See all newsBrief: Lantern Pharma Receives Taiwan Approvals To Open Next Stage Of Phase 2 Harmonic Trial Of Lp-300 In Never-Smoker, Egfr-Mutant Nsclc
Brief: Lantern Pharma Reports Second Quarter 2026 Financial Results And Provides Business Update
Lantern Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Lantern Pharma Q2 operating loss widens on warrant expenses tied to higher stock price
Lantern Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview